About Abbott Laboratories 
Abbott Laboratories
Pharmaceuticals & Biotechnology
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Company focuses on cardiovascular, diabetes care, diagnostics, neuromodulation, nutrition and medicine. It offers products, including FreeStyle, PediaSure, Pedialyte, Similac, EleCare, ZonePerfect, Juven, Ensure and Glucerna. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. The cardiovascular's products include Portico, MitraClip, Dilatation Catheter, among others. The diagnostics products include IntelliFISH, Vysis ALK, STARLIMS, PathVysion, AlinIQ, among others.
Company Coordinates 
Company Details
100 Abbott Park Rd , ABBOTT PARK IL : 60064-3500
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 244 Schemes (32.63%)
Foreign Institutions
Held by 612 Foreign Institutions (16.64%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Miles White
Executive Chairman of the Board
Mr. Robert Ford
President, Chief Executive Officer, Director
Mr. William Osborn
Lead Independent Director
Dr. Robert Alpern
Independent Director
Ms. Roxanne Austin
Independent Director
Ms. Sally Blount
Independent Director
Ms. Michelle Kumbier
Independent Director
Revenue and Profits:
Net Sales:
11,142 Million
(Quarterly Results - Jun 2025)
Net Profit:
1,800 Million
Pharmaceuticals & Biotechnology
USD 258,487 Million (Large Cap)
19.00
NA
0.00%
0.12
27.85%
5.11






